Article Versions Notes

Cehofski LJ, Kruse A, Mæng MO, Sejergaard BF, Schlosser A, Sorensen GL, Grauslund J, Honoré B, Vorum H. Dexamethasone Intravitreal Implant Is Active at the Molecular Level Eight Weeks after Implantation in Experimental Central Retinal Vein Occlusion. Molecules. 2022; 27(17):5687. https://doi.org/10.3390/molecules27175687

Cehofski, Lasse Jørgensen, Anders Kruse, Mads Odgaard Mæng, Benn Falch Sejergaard, Anders Schlosser, Grith Lykke Sorensen, Jakob Grauslund, Bent Honoré, and Henrik Vorum. 2022. "Dexamethasone Intravitreal Implant Is Active at the Molecular Level Eight Weeks after Implantation in Experimental Central Retinal Vein Occlusion" Molecules 27, no. 17: 5687. https://doi.org/10.3390/molecules27175687

Cehofski, L. J., Kruse, A., Mæng, M. O., Sejergaard, B. F., Schlosser, A., Sorensen, G. L., Grauslund, J., Honoré, B., & Vorum, H. (2022). Dexamethasone Intravitreal Implant Is Active at the Molecular Level Eight Weeks after Implantation in Experimental Central Retinal Vein Occlusion. Molecules, 27(17), 5687. https://doi.org/10.3390/molecules27175687